Luı́s F. Maia

Tafamidis for transthyretin familial amyloid polyneuropathy

Teresa Coelho, Luı́s F. Maia, Ana Silva et al. · Neurology · 2012 · 774 citations · Full text

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

Mehtap Bacioglu, Luı́s F. Maia, Oliver Preische et al. · Neuron · 2016 · 402 citations · Full text

Neurodegenerative Diseases, Neurofilament Light Chain, Disease Progression +11

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Teresa Coelho, Luı́s F. Maia, Ana Silva et al. · Journal of Neurology · 2013 · 333 citations · Full text

Alzheimer's Disease, Long-term Effects, Disease Progression +10

The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease

Veronica Hirsch‐Reinshagen, Luı́s F. Maia, Braydon L. Burgess et al. · Journal of Biological Chemistry · 2005 · 228 citations · Full text

Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein

Luı́s F. Maia, Stephan A. Kaeser, Julia Reichwald et al. · Science Translational Medicine · 2013 · 208 citations